Figures & data
Figure 1. Flow chart of patient inclusion in the study. BCR: Biochemical recurrence; HT: Hormonal therapy; PC: Prostate Cancer.
![Figure 1. Flow chart of patient inclusion in the study. BCR: Biochemical recurrence; HT: Hormonal therapy; PC: Prostate Cancer.](/cms/asset/0f4a81fc-ace3-41e8-b0c9-be17d569c222/isju_a_2108140_f0001_b.jpg)
Table 1. Age, tumour characteristics and postoperative radiotherapy according to years from surgery to biochemical recurrence.
Figure 3. (a) Kaplan–Meier plot of biochemical recurrence-free survival after radical prostatectomy with 95% confidence intervals. At least one postoperative PSA <0.2 mg/ml was required for inclusion, hence there are no recurrences within the first months. Curve is truncated when number at risk falls below ten. BCR – biochemical recurrence. (b) Kaplan–Meier plot of failure-free survival after BCR according to time from surgery to BCR with 95% confidence intervals. Each curve is truncated when number at risk in the group falls below ten. BCR: Biochemical recurrence.
![Figure 3. (a) Kaplan–Meier plot of biochemical recurrence-free survival after radical prostatectomy with 95% confidence intervals. At least one postoperative PSA <0.2 mg/ml was required for inclusion, hence there are no recurrences within the first months. Curve is truncated when number at risk falls below ten. BCR – biochemical recurrence. (b) Kaplan–Meier plot of failure-free survival after BCR according to time from surgery to BCR with 95% confidence intervals. Each curve is truncated when number at risk in the group falls below ten. BCR: Biochemical recurrence.](/cms/asset/b8965845-c65e-4691-a6ff-e5fa027d514d/isju_a_2108140_f0003_c.jpg)
Table 2. Pairwise comparison of the distribution of failure-free survival according to category of time to biochemical recurrence as in .